Article

Broad human and animal coronavirus neutralisation by SARS-CoV-2 S2-targeted vaccination

2021-12-01

Abstract excerpt

Several common-cold coronaviruses (HCoVs) are endemic in humans and several variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged during the current Coronavirus disease 2019 (COVID-19) pandemic. Whilst antibody cross-reactivity with the Spike glycoproteins (S) of diverse coronaviruses has been documented, it remains unclear whether such antibody responses, typically targeting the co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0582fd38-1f67-5c3c-97d6-3719de86c287
DOI: 10.1101/2021.11.30.470568

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Broad human and animal coronavirus neutralisation by SARS-CoV-2 S2-targeted vaccinationDOI 10.1101/2021.11.30.470568Read

Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodySemantic proximity Read

SARS coronavirus vaccines protect against different coronavirusesSemantic proximity Read

Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerabilitySemantic proximity Read

Prime-boost protein subunit vaccines against SARS-CoV-2 are highly immunogenic in mice and macaquesSemantic proximity Read

Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female miceSemantic proximity Read

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaquesSemantic proximity Read

Differential Patterns of Cross-Protection against Antigenically Distinct Variants in Small Animal Models of SARS-CoV-2 InfectionSemantic proximity Read

An intranasal vaccine durably protects against SARS-CoV-2 variants in miceSemantic proximity Read

Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunitySemantic proximity Read

Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccinationSemantic proximity Read

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2Semantic proximity Read

Cross-reactive antibodies after SARS-CoV-2 infection and vaccinationSemantic proximity Read